Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-1,750
Closed -$1.44M 11
2016
Q3
$1.44M Sell
1,750
-500
-22% -$432K 14.83% 2
2016
Q2
$1.88M Buy
2,250
+750
+50% +$626K 21.69% 1
2016
Q1
$1.38M Sell
1,500
-1,500
-50% -$1.43M 6.03% 8
2015
Q4
$3.09M Sell
3,000
-750
-20% -$753K 9.06% 5
2015
Q3
$3.84M Hold
3,750
6.55% 2
2015
Q2
$3.91M Buy
+3,750
New +$3.93M 7.96% 2

Other funds holding AGN.PRA

Altegris Advisors's AGN.PRA Position: Q4 2016 in Review

Altegris Advisors sold out of Allergan plc (AGN.PRA) in Q4 2016, closing a stake of 1,750 shares — an estimated $1.44M sold.

Altegris Advisors first reported a position in AGN.PRA in Q2 2015 and held it in 6 quarters. The position peaked at $3.91M in Q2 2015. 108 funds tracked by Wall St. Rank hold AGN.PRA as of Q4 2016.

  • Altegris Advisors reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Altegris Advisors sold 1,750 Allergan plc shares in Q4 2016, an estimated $1.44M.
  • Altegris Advisors first reported a position in Allergan plc in Q2 2015 and held it in 6 quarters.
  • Altegris Advisors's Allergan plc position peaked at $3.91M in Q2 2015.
  • 108 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Altegris Advisors's 13F filing for Q4 2016, filed 8 Feb 2017.